OTC · Medical - Devices

Anteris Technologies Ltd (AMEUF) Stock

$5.70 -35.81% OTC: AMEUF Healthcare

Anteris Technologies Ltd. is a medical device company focused on structural heart solutions.

Valuation

MetricValue
Price$5.70
Market Cap$120.50M
P/E Ratio-3.37
P/B Ratio-3151.93
P/S Ratio175.91
EPS (TTM)$-6.09
52-Week High$15.53
52-Week Low$5.55
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-715.34%
ROA-378.14%
ROCE-123.30%
Gross Margin69.53%
Operating Margin-3175.00%
Net Margin-3075.00%
Debt/Equity-24.54
Current Ratio0.73

Annual Financials (USD)

Metric20202021202220232024
Revenue$7.0M$8.0M$5.0M$4.0M$4.0M
Operating Profit$-17.0M$-21.0M$-45.0M$-70.0M$-127.0M
Net Profit$-15.0M$-23.0M$-44.0M$-67.0M$-123.0M
EPS$-2.58$-3.09$-3.32$-4.31$-6.09
Op Margin-243.0%-270.5%-979.1%-1737.0%-2899.4%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$13.0M$29.0M$23.0M$46.0M$130.0M
Total Liabilities$10.0M$15.0M$10.0M$17.0M$29.0M
Cash$4.0M$21.0M$14.0M$31.0M$114.0M
Borrowings$4.0M$6.0M$1.0M$3.0M$2.0M

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-14.0M$-19.0M$-39.0M$-51.0M$-99.0M
Investing Cash Flow$7.0M$-2.0M$-4.0M$-7.0M$-7.0M
Financing Cash Flow$0$-2.0M$-3.0M$-1.0M$186.0M
Net Cash Flow$-5.0M$17.0M$-7.0M$17.0M$83.0M
Free Cash Flow$-15.0M$-20.0M$-41.0M$-55.0M$-103.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.08
EV / EBITDA-3.38
FCF Yield-13.04%
Quick Ratio0.73
Interest Coverage-3551.09
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CKMTFCarmat S.A. $12.75 -50.96% -0.04 $85.19M 0.00%
CMXCCell MedX Corp. $0.43 — -11.01 $126.33M 0.00%
COLRFTian An Medicare Limited $0.08 +0.00% -34.41 $80.84M 0.00%
COPHFCreso Pharma Limited $0.12 +0.00% -0.40 $131.72M 0.00%
EPRXFEupraxia Pharmaceuticals Inc. $3.04 -6.17% -6.15 $108.29M 0.00%

About Anteris Technologies Ltd

Anteris Technologies Ltd. is a medical device company focused on structural heart solutions. The firm manufactures and commercializes ADAPT, an advanced regenerative tissue product. Additionally, Anteris is actively developing DurAVRTM, a novel 3D, single-piece aortic valve designed to treat aortic stenosis. The company also conducts research and development in the broader field of regenerative medicines. Established in 1999, it changed its name from Admedus Limited to Anteris Technologies Ltd. in May 2020 and is headquartered in Toowong, Australia.

Anteris Technologies Ltd is headquartered in AU.

Anteris Technologies Ltd (AMEUF) stock trades at $5.70 with a market capitalization of $120.50M. The stock is valued at a price-to-earnings (P/E) ratio of -3.37, price-to-book of -3151.93, price-to-sales of 175.91. Over the past 52 weeks the stock has ranged between $5.55 and $15.53, and currently trades 63.3% below its 52-week high.

On profitability, Anteris Technologies Ltd generates a return on equity (ROE) of -715.34%, return on capital employed of -123.30%, an operating margin of -3175.00%, a net profit margin of -3075.00%.

Official website: www.anteristech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides